Welcome to BDA

  "The future of molecular targeted therapy requires a detailed understanding of translational R&D and economics."


Home Navigation Navigation Pre-clinical Navigation Clinical Navigation News Navigation Events Navigation Links Navigation Contacts Navigation Information

    Wed 08 Sep 2010

Latest BDA Events
8th – 10th September 2010
Biotherapy of Cancer (BTOC 10)
Klinikum der Universität München
Programme
Register
_______________________

Latest events

 
BDA Information
Click here to request information from BDA

Change text size

© 2009 Biotherapy Development Association




BDA Scientific Advisors
The BDA Scientific Advisors consists of the following eminent members:

Charles Swanton
Charles Swanton MRCP BSc FSB PhD - CR-UK/MRC Group leader of the Translational Cancer Therapeutics Laboratory at the CR-UK London Research Institute and Consultant medical oncologist at the Royal Marsden Hospital in the Breast and Drug Development Units
Professor Gillies Vassal



Gilles Vassal, MD, PhD, Professor of Oncology, Direction of Clinical and Translational Research, Institut de Cancérologie Gustave-Roussy

Professor Michael Marty

Professor Michel Marty,Director of Centre for Therapeutic Innovation in Oncology and Hematology in Saint Louis University Hospital (Paris, France)
Professor Angus Dalgleish

Prof. Angus Dalgleish, Oncology Division, St George's Medical School, London, UK

Professor Chris McCabe


Professor Chris McCabe, Unit of Health Economics, University of Leeds,UK,
Professor Ian Ellis

Prof Ian Ellis Professor of Cancer Pathology at the University Hospital, Nottingham, UK
Professor Ashley Grossman
Prof Ashley Grossman, Professor of Neuroendocrinology at Bartholomew’s and the London School of Medicine
Dr Steven Hirschfeld

Dr Steven Hirschfeld - Associate Director Clinical Research, National Institute of Child health and Human Development, Bethesda, USA
Professor Pat Price

Prof. Pat Price Director of Radiation Oncology, University of Manchester UK
 

Prof. Bernie Fox Director of Oncology Research, Earle A. Chiles Research Institute, Portland, Oregon, USA

 

Professor Giampietro Gasparini University Hospital, Rome, Italy


 

Prof. Gustav Gaudernack Director of Oncology, University of Oslo, Norway

 

Prof. Rolf Kiessling, Kalrolinska Institute, Stockholm, Sweden

 

Prof. Klaus Pantel Director Institute for Tumour Biology, University of Hamburg, Germany

 

Prof. Jamie Zwiebel, Chief for Biologics Evaluation, National Cancer Institute, Maryland, USA



Web site created and maintained using   link to web4work